Corbus Pharmaceuticals Holdings Inc (CRBP)
33.50
-2.04
(-5.74%)
USD |
NASDAQ |
Apr 25, 16:00
33.63
+0.13
(+0.39%)
After-Hours: 20:00
Corbus Pharmaceuticals Holdings Total Liabilities (Quarterly): 35.18M for Dec. 31, 2023
Total Liabilities (Quarterly) Chart
Historical Total Liabilities (Quarterly) Data
| Date | Value |
|---|---|
| December 31, 2023 | 35.18M |
| September 30, 2023 | 35.97M |
| June 30, 2023 | 34.20M |
| March 31, 2023 | 35.19M |
| December 31, 2022 | 33.32M |
| September 30, 2022 | 31.88M |
| June 30, 2022 | 32.60M |
| March 31, 2022 | 34.52M |
| December 31, 2021 | 38.62M |
| September 30, 2021 | 41.95M |
| June 30, 2021 | 43.65M |
| March 31, 2021 | 48.63M |
| December 31, 2020 | 57.02M |
| September 30, 2020 | 66.61M |
| June 30, 2020 | 49.70M |
| March 31, 2020 | 42.51M |
| December 31, 2019 | 42.98M |
| September 30, 2019 | 38.49M |
| June 30, 2019 | 36.75M |
| March 31, 2019 | 59.09M |
| Date | Value |
|---|---|
| December 31, 2018 | 19.47M |
| September 30, 2018 | 18.31M |
| June 30, 2018 | 14.80M |
| March 31, 2018 | 11.60M |
| December 31, 2017 | 9.195M |
| September 30, 2017 | 6.439M |
| June 30, 2017 | 6.975M |
| March 31, 2017 | 7.021M |
| December 31, 2016 | 8.969M |
| September 30, 2016 | 6.443M |
| June 30, 2016 | 4.974M |
| March 31, 2016 | 4.091M |
| December 31, 2015 | 3.890M |
| September 30, 2015 | 2.16M |
| June 30, 2015 | 2.796M |
| March 31, 2015 | 0.5548M |
| December 31, 2014 | 0.738M |
| September 30, 2014 | 0.6137M |
| December 31, 2013 | 2.089M |
Total Liabilities Definition
Liabilities are a main portion of the balance sheet of a company that measure outstanding payables/obligations. A few examples of liabilties of a company include accounts payable, current debt, and capital lease obligations. From an accounting perspective, the balance sheet equation is Liabilties = Assets - Shareholder's Equity.
Total Liabilities (Quarterly) Range, Past 5 Years
31.88M
Minimum
Sep 2022
66.61M
Maximum
Sep 2020
41.04M
Average
38.49M
Median
Sep 2019
Total Liabilities (Quarterly) Benchmarks
| Panbela Therapeutics Inc | 16.51M |
| Processa Pharmaceuticals Inc | 0.7975M |
| Protalix BioTherapeutics Inc | 50.86M |
| Spectral AI Inc | 10.88M |
| Vera Therapeutics Inc | 73.86M |
Total Liabilities (Quarterly) Related Metrics
| Total Assets (Quarterly) | 28.27M |
| Shareholders Equity (Quarterly) | -6.905M |